Pretreatment Thrombocytosis as a Prognostic Factor in Metastatic Breast Cancer
Open Access
- 24 June 2013
- journal article
- research article
- Published by Wiley in International Journal of Breast Cancer
- Vol. 2013, 1-6
Abstract
Background. An elevated platelet count is often associated with malignancies, and it has been confirmed as an adverse prognostic factor in various cancers including early stage breast cancer. We sought to determine if thrombocytosis is also a prognostic factor in metastatic breast cancer. Patients and Methods. The records of 165 metastatic breast cancer patients with complete follow-up that had thrombocytosis or normal platelet counts were reviewed. Kaplan-Meier curves were constructed, and the survivals of the two groups were compared using the LogRank test. A Cox regression analysis was used to determine if thrombocytosis is an independent factor for overall and progression free survival. Results. There was a statistically significant difference in overall and progression free survival favoring the normal platelets group (LogRank test and 0.008, resp.). Thrombocytosis remained a significant adverse prognostic factor in multivariate analysis. Other independent prognostic factors for overall survival included age, ER/PR status, and grade. Conclusion. Thrombocytosis represents an independent adverse prognostic factor in patients with metastatic breast cancer. Thus metastatic breast cancer joins a range of cancers in which this easily measurable value can be used for clinical prognostication. Further use as a predictive value for specific treatments has a rationale and deserves to be investigated.Keywords
This publication has 29 references indexed in Scilit:
- Impact of pretreatment thrombocytosis on blood-borne metastasis and prognosis of gastric cancerEuropean Journal of Surgical Oncology, 2012
- Paraneoplastic Thrombocytosis in Ovarian CancerNew England Journal of Medicine, 2012
- Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes MetastasisCancer Cell, 2011
- How platelets safeguard vascular integrityJournal of Thrombosis and Haemostasis, 2011
- Thrombocytosis: Diagnostic Evaluation, Thrombotic Risk Stratification, and Risk-Based Management StrategiesThrombosis, 2011
- Vascular Endothelial Growth Factor in the Circulation in Cancer Patients May Not Be a Relevant BiomarkerPLOS ONE, 2011
- Innate Immune Cells Induce Hemorrhage in Tumors during ThrombocytopeniaThe American Journal of Pathology, 2009
- The basics of epithelial-mesenchymal transitionJournal of Clinical Investigation, 2009
- Guidelines for Human Epidermal Growth Factor Receptor 2 Testing: Biologic and Methodologic ConsiderationsJournal of Clinical Oncology, 2009
- Poor Prognosis Associated With Thrombocytosis in Patients With Gastric CancerAnnals of Surgical Oncology, 2002